News and Trends 15 Apr 2019 First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials …the damage. The patients were followed for up to three months after they received the therapy. Two patients given the highest doses of the cell therapy suffered from events such… April 15, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 2 Oct 2017 Belgian Biotech Breaks New Ground in Fight Against Life-Threatening Blood Disorder …caused the company’s value on the stock market to spike. The drug met primary and secondary endpoints including improved platelet response and reduced risk of aTTP-related events or death. In… October 2, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2025 BIO-Europe partnering: Australian biotech companies share their experiences …few returns. As one biotech CEO put it, “raising money in Australia is an uphill battle” and so events like BIO-Europe become critical to achieving a development path forward. Next… November 10, 2025 - 9 minutesmins - By Dylan Kissane Share WhatsApp Twitter Linkedin Email
More News! 20 Jan 2018 These Artists Recreate the Origins of Life with Bioluminescence …today’s phytoplankton, but it is unknown the exact reason why it evolved. On Earth, some bioluminescence events can be seen from outer space. On a planet where early life was… January 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jun 2021 Farxiga’s Approval Fuels Chronic Kidney Disease Comeback …drug developed by Novo Nordisk reduced signs of atherosclerosis in CKD patients in phase II. And Bayer’s drug finerenone lowered the risk of cardiovascular events like heart attacks and strokes… June 8, 2021 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
About Us …is sourced from press releases, direct interviews, reports, events, and industry databases. We also receive tips from readers and always respect their anonymity when requested. Labiotech.eu also publishes occasional contributions… April 8, 2024 - 1 minutemin - By Developer Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Sep 2025 CRISPR technology’s next wave: Ten companies to watch in 2025 …day 30. Engraftment was rapid, with neutrophils returning by day 14 and platelets by day 19, and there were no serious adverse events linked to the therapy. Prime described these… September 30, 2025 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 21 Feb 2023 New event set to take place in Swedish biotech hub …is their inspirational and transforming research that is providing the basis for a number of therapeutic applications,” Grundemar said. With a calendar already filled with biotech events, what prompted setting… February 21, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jan 2024 2024 J.P. Morgan Healthcare Conference: key takeaways from the largest biotech gathering of the year …of Anavo. “The recent M&As point to a potential increase in new capital to be invested.” As networking events can foster investments and growth, Lars Nieba, CEO of Engimmune, pointed… January 18, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 28 Feb 2023 What’s happening on Rare Disease Day? …more than 600 events taking place to raise awareness. Image/RareDiseaseDay.org Rare Disease Day 2023: marking the event To mark the event, the Rare Disease Diversity Coalition (RDDC) – an initiative… February 28, 2023 - 8 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 12 May 2023 5 highlights at first Genomics and Precision Medicine Expo …for registered healthcare professionals and individuals working in the field of genomics and precision medicine (excluding commercial companies) and is fully CPD accredited. The co-located events feature 150+ sessions across… May 12, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jun 2025 ASCO 2025: key highlights in cancer therapeutics …Tedopi induced a 65% overall survival rate after 12 months. Around 26% patients in the drug cohort experienced serious adverse events, out of which 6% were found to be linked… June 4, 2025 - 18 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email